Alatrofloxacin
Alatrofloxacin
Alatrofloxacin (/ˌælətroʊˈflɒksəsɪn/) is a fluoroquinolone antibiotic that was used in the form of its mesylate ester, alatrofloxacin mesylate. It is a prodrug of trovafloxacin.
Etymology
The term "Alatrofloxacin" is derived from the parent drug "Trovafloxacin," with the prefix "Ala-" indicating the alanine moiety added to make the prodrug.
Pharmacology
Alatrofloxacin is administered intravenously and is converted to trovafloxacin, its active metabolite, in the liver. Trovafloxacin exerts its antibacterial activity by inhibiting the bacterial enzymes DNA gyrase and topoisomerase IV, which are required for bacterial DNA replication, transcription, repair, and recombination.
Clinical Use
Alatrofloxacin was used to treat adults with lower respiratory tract infections and complicated skin and skin structure infections caused by susceptible strains of certain bacteria. However, its use was discontinued due to hepatotoxicity concerns.
Related Terms
See Also
External links
- Medical encyclopedia article on Alatrofloxacin
- Wikipedia's article - Alatrofloxacin
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski